Ayón Chang, C., Castán, D., Mora Carmona, A., Naranjo, D., Obando, F., & Mora Román, J. J. (2022). Monoclonal antibodies: A therapeutic option for the treatment of ophthalmic diseases of the eye posterior segment.
استشهاد بنمط شيكاغوAyón Chang, Catalina, Daniel Castán, Adrián Mora Carmona, Dunia Naranjo, Francini Obando, و Juan José Mora Román. Monoclonal Antibodies: A Therapeutic Option for the Treatment of Ophthalmic Diseases of the Eye Posterior Segment. 2022.
MLA استشهادAyón Chang, Catalina, et al. Monoclonal Antibodies: A Therapeutic Option for the Treatment of Ophthalmic Diseases of the Eye Posterior Segment. 2022.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.